Key Drivers
- High gross margin
- Negative equity
- Negative FCF
AIAI Summary
Indivior is now a high‑conviction, SUBLOCADE‑centric profitability bet—its attractive ~80% gross margins and targeted $150M OpEx cuts can drive EBITDA and FCF upside, but the investment hinges on execution-driven cash conversion rather than pipeline optionality. Investors should watch for sustainably positive operating cash flow and improving working capital within 2–4 quarters (or clearer payer/access wins) as the specific trigger for re-rating; failure to deliver would magnify dilution, solvency, and single‑product risk.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High gross margin
- •Negative equity
- •Negative FCF
INDV shows strong reported profitability and unit economics but faces acute liquidity strain, negative equity and persistent negative free cash flow that materially elevate balance-sheet and cash-generation risk.
Price Behavior
Key Price Behavior Insights:
- •Below last-month SMA
- •Support at ~$29.3
- •Resistance cluster ~$31–$33.5
Price is in a short-term downtrend, trading ~8–9% below its last-month SMA (~$32.03) with bearish momentum (RSI ~35) and a key near-term support at ~$29.30 that, if broken, would raise downside risk while reclaiming $31.0–$33.5 is needed to confirm a reversal.
Price fell ~12% from $33.34 on 2026-03-10 to $29.31 on 2026-03-20, indicating heightened short-term volatility
Sentiment & News
Key News Insights:
- •Convertible upsized
- •Positive adherence
- •Correctional access
Between late Feb and mid‑Mar 2026 Indivior reported FY2025 results, engaged investors, upsized a $450M convertible note, and released SUBLOCADE adherence data while highlighting persistent correctional access gaps.
The $450M convertible strengthens liquidity and supports commercialization/clinical plans, and favorable adherence data boosts product value, but correctional access gaps could constrain uptake
Similar Companies in Healthcare
Other companies in the same sector with AI ratings